• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肿瘤患者的心律失常：临床医生的简明概述。

Arrhythmias in oncological patients: a compact overview for the clinician.

机构信息

Clinic for Cardiology and Electrophysiology, Evangelical Hospital Hagen-Haspe, Brusebrinkstraße 20, 58135, Hagen, Germany.

School of Medicine, Witten/Herdecke University, Witten, Germany.

出版信息

Herzschrittmacherther Elektrophysiol. 2024 Sep;35(3):177-182. doi: 10.1007/s00399-024-01033-x. Epub 2024 Aug 11.

DOI:10.1007/s00399-024-01033-x
PMID:39129002
Abstract

Chemotherapy is the cornerstone of antineoplastic treatment in patients with malignancies. The cardiotoxic effect of antineoplastic therapy has been known for many decades. Part of chemotherapy-induced cardiotoxicity is the development of heart rhythm disturbances. This short review aims to provide a compact overview for the clinical cardiologist of the dysrhythmic potential created by antineoplastic agents in cancer survivors.

摘要

化疗是恶性肿瘤患者抗肿瘤治疗的基石。几十年来，人们一直都知道抗肿瘤治疗具有心脏毒性作用。化疗引起的心脏毒性的一部分是心律失常的发展。这篇简短的综述旨在为临床心脏病专家提供一个关于癌症幸存者中抗肿瘤药物致心律失常潜力的简明概述。

相似文献

1
Arrhythmias in oncological patients: a compact overview for the clinician.肿瘤患者的心律失常：临床医生的简明概述。
Herzschrittmacherther Elektrophysiol. 2024 Sep;35(3):177-182. doi: 10.1007/s00399-024-01033-x. Epub 2024 Aug 11.
2
Electrophysiology Translational Considerations in Cardio-Oncology: QT and Beyond.电生理学在心血管肿瘤学中的转化研究：QT 及其他。
J Cardiovasc Transl Res. 2020 Jun;13(3):390-401. doi: 10.1007/s12265-019-09924-y. Epub 2019 Oct 31.
3
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.抗癌治疗的心脏毒性：流行病学、检测和管理。
CA Cancer J Clin. 2016 Jul;66(4):309-25. doi: 10.3322/caac.21341. Epub 2016 Feb 26.
4
Cardiotoxicity among adult survivors suffered from childhood malignancies.成年期曾患儿童恶性肿瘤幸存者中的心脏毒性。
Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:34-40.
5
Cancer chemotherapy and cardiac arrhythmias: a review.癌症化疗与心律失常：综述
Drug Saf. 2015 Feb;38(2):129-52. doi: 10.1007/s40264-014-0258-4.
6
Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study.长期乳腺癌幸存者的心脏毒性筛查 - CAROLE（心脏相关肿瘤晚期效应）研究。
Cancer Med. 2021 Aug;10(15):5051-5061. doi: 10.1002/cam4.4037. Epub 2021 Jul 10.
7
Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.心脏肿瘤学第一部分：化疗与心血管毒性
Expert Rev Cardiovasc Ther. 2015 May;13(5):511-8. doi: 10.1586/14779072.2015.1032940. Epub 2015 Apr 5.
8
Cardiotoxicity of cancer chemotherapy: implications for children.癌症化疗的心脏毒性：对儿童的影响
Paediatr Drugs. 2005;7(3):187-202. doi: 10.2165/00148581-200507030-00005.
9
Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.超声心动图及其他心脏影像学在肿瘤幸存者接受化疗和/或辐射治疗后长期心脏毒性监测中的应用。
Curr Oncol Rep. 2016 Aug;18(8):52. doi: 10.1007/s11912-016-0532-y.
10
Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.管理儿童癌症幸存者的化疗相关心脏毒性
Paediatr Drugs. 2014 Oct;16(5):373-89. doi: 10.1007/s40272-014-0085-1.

引用本文的文献

1
Arrhythmias, conduction disorders and sudden cardiac death in cancer patients and survivors: expert opinion of the working groups on cardio-oncology and on electrophysiology of the hellenic cardiac society.癌症患者及其幸存者的心律失常、传导障碍与心源性猝死：希腊心脏病学会心脏肿瘤学与电生理学工作组专家意见
Cardiooncology. 2025 Jul 28;11(1):71. doi: 10.1186/s40959-025-00363-0.
2
[The challenge: specialization meets general medicine].[挑战：专科医学与全科医学的相遇]
Herzschrittmacherther Elektrophysiol. 2024 Sep;35(3):175-176. doi: 10.1007/s00399-024-01034-w. Epub 2024 Aug 22.

本文引用的文献

1
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: State-of-the-Art Review.心脏肿瘤学基础与转化科学的优先事项：GCOS 2023研讨会论文集：最新综述
JACC CardioOncol. 2023 Sep 27;5(6):715-731. doi: 10.1016/j.jaccao.2023.08.003. eCollection 2023 Dec.
2
A Review of 10-Year Survivability of Immunotherapy in the Management of Colon Cancer.免疫疗法治疗结肠癌的10年生存率综述
Cureus. 2023 Aug 9;15(8):e43189. doi: 10.7759/cureus.43189. eCollection 2023 Aug.
3
Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost.
心肌保护与当前癌症治疗：两个截然相反的目标，必然付出代价。
Int J Mol Sci. 2022 Nov 15;23(22):14121. doi: 10.3390/ijms232214121.
4
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会（ESC）与欧洲血液学协会（EHA）、欧洲治疗放射学与肿瘤学协会（ESTRO）以及国际心脏肿瘤学会（IC-OS）合作制定的心脏肿瘤学指南。
Eur Heart J. 2022 Nov 1;43(41):4229-4361. doi: 10.1093/eurheartj/ehac244.
5
The Wild West of Checkpoint Inhibitor Development.免疫检查点抑制剂研发的蛮荒西部
N Engl J Med. 2022 Apr 7;386(14):1297-1301. doi: 10.1056/NEJMp2116863. Epub 2021 Dec 15.
6
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review.免疫检查点抑制剂相关的心脏毒性：一项系统评价。
Cancers (Basel). 2021 Oct 18;13(20):5218. doi: 10.3390/cancers13205218.
7
Clinical efficacy and safety of angiogenesis inhibitors: sex differences and current challenges.血管生成抑制剂的临床疗效与安全性：性别差异及当前挑战
Cardiovasc Res. 2022 Mar 16;118(4):988-1003. doi: 10.1093/cvr/cvab096.
8
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque.免疫检查点抑制剂与心血管事件及动脉粥样硬化斑块的关系。
Circulation. 2020 Dec 15;142(24):2299-2311. doi: 10.1161/CIRCULATIONAHA.120.049981. Epub 2020 Oct 2.
9
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。
N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.
10
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.癌症治疗的心脏不良影响：心脏毒性和心律失常。
Nat Rev Cardiol. 2020 Aug;17(8):474-502. doi: 10.1038/s41569-020-0348-1. Epub 2020 Mar 30.